Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd. is a Chinese private company located in Chengdu. The firm manufactures pharmaceuticals.

Reliance Life Sciences is a diverse and integrated biotechnology initiative of the Reliance Group of companies. The Reliance Group is India’s largest private sector enterprise, with annual revenues of US$ 66.8 billion. The Group’s activities span oil and gas exploration and production, petroleum refining, petrochemicals, polyester, plastics, organized retailing and telecom. The Group’s flagship company Reliance Industries Limited is the largest private sector company and a Fortune Global 500 company. Reliance Life Sciences is part of the Promoter Group of Reliance Industries Limited. RLS was established to develop business opportunities in medical biotechnology with key initiatives in biopharmaceuticals, pharmaceuticals, regenerative medicine, clinical research and molecular diagnostics.

Octapharma is a privately-owned global human proteins manufacturer headquartered in Lachen, Switzerland. Since its establishment in 1983 the company has been dedicated to improving the lives of patients. Octapharma was founded in 1983 on the fundamental principle of improving the lives of patients. Since then we have remained focused on our collective responsibility for the trust instilled in us by physicians and patients worldwide. In 2012, the Octapharma Board identified the core strategic pillars which will lead to the achievement of the organization’s ambitious long term goals.

Suzhou Liangchen Biomedical Technology Co., Ltd., established on 2010-03-18, Business scope includes licensed projects:Inspection and testing service;Technology Import and Export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Engineering and Technology Research and Experimental Development(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Haemacure Corp. is engaged in the development, marketing and sales of surgical sealants and related medical devices. Its primary product is a fibrin sealant, a tissue sealant comprised of fibrinogen and thrombin extracted from human plasma. The fibrin sealant is used in surgical procedures to arrest bleeding and as an adjunct to wound healing. It was founded on August 19, 1991 and is headquartered in Montreal, Canada.

Elanco U.S., Inc. develops products and services that enhance animal health, wellness, and performance. The company was founded on December 16, 1996 and is headquartered in Greenfield, IN.

Omrix Biopharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets biological products for the biosurgical and immunotherapy markets.

Guizhou Taibang Biological Products Co., Ltd. engages in research, development, production and sale of blood products and biochemical drugs. Its products include human serum albumin, human immunoglobulin, intravenous human immunoglobulin, hepatitis B human immunoglobulin, rabies immune globulin, tetanus human immunoglobulin, human prothrombin complex, and placental polypeptide injection. The company was founded on May 21, 1996 and is head quartered in Guiyang, China.

PAFC Bio Pharmaceutical is a biopharmaceutic company focused on researching and developing, manufacturing, and selling plasma products. The company implements the general manager responsibility system under the leadership of the board of directors. The company has 10 plasma collection stations in Heilongjiang province, and 1 plasma collection station in Sichuan Province, which are responsible for the collection and supply of raw material plasma. There are 10 functional departments such as the production department, quality assurance department, and equipment division.

Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France.

Shanghai New Shield Technology Co., Ltd., established on 2009-03-09, The scope of business includes electronic computers,New Chemical Materials,Photoelectric integration,Communications Engineering,Technology development in the field of environmental technology,technology transfer,technical consulting,Technical Services;Business Consulting;building materials,Class I medical device,Sales of Electronics;Engaged in the import and export of goods and technology,Own house rental. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Jiangsu Kangyuan Ruiao Biomedical Technology Co., Ltd., established on 2018-10-30, Business scope includes biomedical technology research and development;production of medicines,Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)***

Part of Shanghai RAAS Blood Products Co., Ltd., Tonrol Biological Pharmaceutical Co. Ltd. is a Chinese company located in Hefei. The firm develops blood solutions such as human serum albumin, IgG and IVIG. On December 19, 2014 Shanghai RAAS Blood Products Co., Ltd. acquired Tonrol Biological Pharmaceutical Co. Ltd. for $1,064.85 million.

Guangzhou Bairuikang Biotechnology Co., Ltd., established on 2016-07-14, Business scope includes cell technology research and development and application;Natural science research and experimental development;Research on policies and regulations;Medical Research and Experimental Development;Research and development of bio-based materials technology;Sales of bio-based materials;Sales of new organic active materials;Extraction of marine bioactive substances,purification,Synthesis technology research and development;Development of Human Gene Diagnosis and Therapy Technology;Human stem cell technology development and application;Biochemical product technology research and development;Engineering and Technology Research and Experimental Development;New material technology research and development;Agricultural Science Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of daily chemical products;Chemical product sales(No licensed chemical products);Specialty Chemicals Sales(Free of Hazardous Chemicals);Manufacturing of daily chemical products;Chemical product production(No licensed chemical products);Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Personal Hygiene Sales;Sales of hygiene products and single-use medical products;Maternal and baby products sales;Medical Mask Retail;Wholesale medical masks;daily mask(non-medical)Sales;Wholesale of protective equipment for medical staff;Retailing of protective equipment for healthcare workers;Disinfectant sales(Free of Hazardous Chemicals);Sales of Class II Medical Devices;Sales of Class I Medical Devices;Production of Class I Medical Devices;Production of protective equipment for medical personnel(Ι class medical device);daily mask(non-medical)Production;brand management;Business Management Consulting;business management;Socioeconomic Advisory Services;Information Consulting Service(Not including licensing information consulting services);Information Technology Consulting Services;Inspection and testing service;Drug import and export;pharmaceutical production;Drug retail;Drug Wholesale;Technology Import and Export;Import and export;Production of Class II Medical Devices;Production of protective equipment for medical personnel(Class II medical device);Production of hygiene products and single-use medical products;Production of medical masks;Production of sterile equipment;

Part of Zoetis, Inc., Zoetis Services LLC is a company headquartered in Florham Park, NJ, that discovers, develops, manufactures and sells animal health medicines and vaccines.

Biotest is a specialist in innovative haematology, clinical immunology and intensive care medicine. Biotest develops, manufactures and markets plasma proteins and biotherapeutic drugs. Their value chain extends from pre-clinical and clinical development to worldwide marketing and distribution. Biotest manufactures immunoglobulins, clotting factors and albumins which derive from human blood plasma. Biotest also develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus which are produced by recombinant technologies. Biotest currently employs more than 2,500 people worldwide. The most important raw material for their pharmaceuticals is human blood plasma, which they process into effective and highly purified drugs in one of their world leading fractionation facilities in Europe. These medications are used to treat life-threatening diseases such as blood coagulation disorders (haemophilia), severe infections and immune system disorders.

Hualan Biological Bacterin Inc. engages in vaccine and related medical supplies production. Its products include various vaccines and genetically engineered biological products. The company was founded on November 9, 2005 and is headquartered in Xinxiang, China.

Information and Communication Company of State Grid Jilin Electric Power Co., Ltd., established on 2006-03-07, Business scope includes power communication and information network construction within the system,Operation of networks and information systems,maintain,Technical support,consult(law,Do not operate where prohibited by law,Items subject to special approval,Do not operate without special approval)*